Ovizio Imaging Systems has executed supply agreements with Celgene Corporation for the automation of certain engineered T cell manufacturing processes.

Celgene will be using Ovizio’s on-line iLine F microscope, and the BioConnect system, a closed, single-use fluidic sampling system, to further automate the manufacturing of engineered T-cell investigational products and improve product control across their global manufacturing network. These agreements follow a technology development cooperative effort initiated in 2018.

Emilie Viey, chief executive officer of Ovizio Imaging Systems, said, “We are proud to support Celgene’s efforts in cell therapy, developing innovative programs for patients in areas of high unmet need. As a supportive technology partner, we are excited for the opportunities ahead as we continue our work with Celgene, seamlessly integrating Ovizio’s innovative microscopy solution into their engineered T-cell products manufacturing process.”